Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Citi
Cerilliant
Accenture
Daiichi Sankyo
Harvard Business School
QuintilesIMS
Dow
Express Scripts

Generated: May 25, 2018

DrugPatentWatch Database Preview

TOTECT Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Totect, and what generic alternatives are available?

Totect is a drug marketed by Clinigen Hlthcare and is included in one NDA. There is one patent protecting this drug.

This drug has twenty-two patent family members in sixteen countries.

The generic ingredient in TOTECT is dexrazoxane hydrochloride. There are six drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the dexrazoxane hydrochloride profile page.
Summary for TOTECT
Drug patent expirations by year for TOTECT
Pharmacology for TOTECT
Medical Subject Heading (MeSH) Categories for TOTECT
Synonyms for TOTECT
(+)-Razoxane hydrochloride
(S)-4,4'-(1-Methyl-1,2-ethanediyl)bis-2,6-piperazinedione hydrochloride
(S)-4,4'-(propane-1,2-diyl)bis(piperazine-2,6-dione) hydrochloride
003D010
1263283-43-7
149003-01-0
2,6-Piperazinedione, 4,4'-((1S)-1-methyl-1,2-ethanediyl)bis-, hydrochloride (1:1)
2,6-Piperazinedione, 4,4'-(1-methyl-1,2-ethanediyl)bis-, hydrochloride, (S)-
4-[(2S)-2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione hydrochloride
5346058Q7S
AC-9014
AC1OCF6D
ADR-529
ADR-529 hydrochloride
AKOS015900046
AN-7454
AOB6763
AOB6863
API0005176
AS-16976
C11H16N4O4.HCl
Cardioxane
CHEBI:50224
CHEMBL1200778
CS-0767
D07807
Dexrazoxane (Hydrochloride)
Dexrazoxane (TN)
Dexrazoxane HCl
Dexrazoxane hydrochloride
Dexrazoxane hydrochloride [ORANGE BOOK]
Dexrazoxane hydrochloride [VANDF]
Dexrazoxane hydrochloride [WHO-DD]
DTXSID60164152
FT-0700082
HY-76201
I14-10061
ICRF 187 hydrochloride
ICRF-187 hydrochloride
KDX-0811
MolPort-023-276-958
Razoxane (+)-form hydrochloride [MI]
Razoxane hydrochloride, (S)-
s1222
Savene
Savene (TN)
SCHEMBL18188
TopoTect
Totect (TN)
UNII-5346058Q7S
UNII-BR9T89F617 component BIFMNMPSIYHKDN-FJXQXJEOSA-N
W-5214
X5010
Zinecard
Zinecard (TN)

US Patents and Regulatory Information for TOTECT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Clinigen Hlthcare TOTECT dexrazoxane hydrochloride INJECTABLE;INJECTION 022025-001 Sep 6, 2007 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Chubb
Farmers Insurance
Federal Trade Commission
Daiichi Sankyo
Mallinckrodt
Johnson and Johnson
McKesson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.